{"id":15680,"date":"2023-11-21T15:59:25","date_gmt":"2023-11-21T14:59:25","guid":{"rendered":"https:\/\/udic.es\/?p=15680"},"modified":"2024-02-14T19:47:04","modified_gmt":"2024-02-14T18:47:04","slug":"an-option-to-modify-the-course-of-parkinsons-progression","status":"publish","type":"post","link":"https:\/\/udic.es\/en\/an-option-to-modify-the-course-of-parkinsons-progression\/","title":{"rendered":"An option to modify the course of Parkinson’s progression"},"content":{"rendered":"
Evaluation of an inhibitor of the LRRK 2 gene in Parkinson’s patients. Oral tract.
\nWe continue the development of our tractaments that aim to modify the natural history of malaria, slowly progressing.<\/p>\n","protected":false},"excerpt":{"rendered":"
Evaluation of an inhibitor of the LRRK 2 gene in Parkinson’s patients. Oral tract. We continue the development of our tractaments that aim to modify the natural history of malaria, slowly progressing.<\/p>\n","protected":false},"author":5,"featured_media":9251,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[130],"tags":[],"class_list":["post-15680","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-parkinson-en"],"yoast_head":"\n